On the move Positive Healthcare Stock: The Cooper Companies, Inc. (NYSE: COO)

On Friday, The Cooper Companies, Inc. (NYSE: COO) shares price traded between $254.81 and $258.75 during the last trading session above with +0.79% at $257.63. The shares recorded a trading volume 224,089 million shares as compared to its average volume of 409,985 shares. The company has 49.1M shares outstanding and market value of 12.651B. Over the one year trading period, the stock has a peak price of $261.71 and its down is recorded at $216.47. The short ratio in the stock is 6.62 and the short float is around of 6.23%.

The Cooper Companies, Inc. (NYSE: COO) reported financial results for the fiscal second quarter ended April 30, 2018.

Second Quarter Operating Results

Revenue $631.3M up 21% from last year’s second quarter, up 5% pro forma (defined as constant currency and including acquisitions in both periods).

Gross margin 64% contrast with 66% in last year’s second quarter. Gross margin was negatively influenced primarily by the before revealed acquisition-related inventory step-up associated with PARAGARD. On a non-GAAP basis, gross margin was 68% contrast with 66% last year.

Operating margin 12% contrast with 22% in last year’s second quarter. The decrease was primarily the result of the PARAGARD inventory step-up and an asset impairment charge within CooperSurgical associated with exiting carrier screening. On a non-GAAP basis, operating margin was 29% contrast with 27%.

Interest expense increased to $18.7M contrast with $7.7M in last year’s second quarter primarily Because of higher debt and interest rates.

Total debt increased $81.2M from January 31, 2018, to $2,483.7M primarily Because of the acquisition of LifeGlobal and higher cash balances.

Cash provided by operations $170.8M offset by capital expenditures $46.5M resulted in  free cash flow of $124.3M, up 21% year-over-year.

The Cooper Companies, Inc.’s (COO) price volatility for a month noted as 1.61% however its price volatility for a week documented as 1.92%. The corporation holds 49.10 million outstanding shares and its 48.77 million shares were floated in the market. The stock established a positive trend of 1.73% in last week and indicated rise of 3.89% in previous month.

Fiscal Year 2018 Guidance

The Company updated its fiscal year 2018 guidance.  Details are summarized as follows:

Fiscal 2018 total revenue $2,515 – $2,550M

CVI revenue $1,870 – $1,890M

CSI revenue $645 – $660M

Fiscal 2018 non-GAAP diluted earnings per share of $11.70 – $11.90

Angela Maria

Angela writes about Dividend news of Healthcare, Services, technology, financial, energy sector companies and other global companies that traded in US market. Before pursuing a financial and journalism career, she graduated from University of Georgia with a degree in Economic and Mathematics.

Leave a Reply

Your email address will not be published. Required fields are marked *